MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

BPO-27 racemate

CAS No. : 1314873-02-3

MCE 站：BPO-27 racemate

产品活性：BPO-27 racemate是有效的CFTR抑制剂，IC₅₀值为8 nM。

研究领域：Membrane Transporter/Ion Channel  |  Autophagy

作用靶点：CFTR  |  Autophagy

In Vitro: The benzopyrimido-pyrrolo-oxazinedione BPO-27 is an analogue of PPQ-102, which inhibits CFTR with an IC₅₀ of 8 nM. The R enantiomer of BPO-27 inhibits CFTR chloride conductance with an IC₅₀ of 4 nM, while S enantiomer is inactive. In vitro metabolic stability in hepatic microsomes shows both enantiomers as stable, with less than 5% metabolism in 4 h. (R)-BPO-27 binds near the canonical ATP binding site. Whole-cell patch-clamp studies shows linear CFTR currents with a voltage-independent (R)-BPO-27 block mechanism. At a concentration of (R)-BPO-27 that inhibits CFTR chloride current by 50%, the EC₅₀ for ATP activation of CFTR increases from 0.27 to 1.77 mM.

In Vivo: Following bolus interperitoneal administration in mice, serum (R)-1 decays with t_1/2 ≈ 1.6 h and gives sustained therapeutic concentrations in kidney.

相关产品：Bioactive Compound Library Plus  |  K41498 TFA  |  Kobusin  |  PG01

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。